TG Therapeutics, Inc. (TGTX): Total Assets
$1.06B
As of 2025-12-31
$1.64B
As of 2026-06-30
+76.4%
3-year compound annual growth
+11.2%
5-year compound annual growth
+25.1%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.06B | +84.1% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $577.69M | +75.3% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $329.59M | +70.3% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $193.57M | -49.0% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $379.63M | -39.3% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $625.64M | +283.8% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $163.01M | +95.0% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $83.62M | -14.1% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $97.38M | +77.8% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $54.78M | -51.7% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $113.47M | +30.8% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $86.75M | +80.3% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $48.11M | +118.0% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $22.07M | +51.8% | 2014-03-07, Balance as of period end |
| 2011-12-31 | $14.54M | n/a | 2013-03-21, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $1.06B | +84.1% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.93B | -12.2% |
| Insmed Inc (INSM) | 2025-12-31 | $2.26B | +11.8% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $689.80M | +21.3% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $1.53B | +1.9% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $598.73M | +20.3% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $763.63M | +31.5% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.45B | +6.2% |
Compare TGTX, OPK, INSM, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗